Enzon Pharmaceuticals, Inc. (ENZN) Concludes Review of Possible Asset Sales, Sale of the Company; Announces $1.60 Special Dividend and Periodic Royalty Dividends
4/24/2013 10:11:38 AM
More...
|
Enzon Pharmaceuticals, Inc. (ENZN) Reports Fourth Quarter and Full Year 2012 Results
3/19/2013 8:59:56 AM
More...
|
Legendary Icahn Still Slugging Away With Enzon Pharmaceuticals, Inc. (ENZN)
1/8/2013 8:32:44 AM
More...
|
Enzon Pharmaceuticals, Inc. (ENZN) to Trim Workforce by About Half, to Stop Drug Development
12/21/2012 7:54:36 AM
More...
|
Enzon Pharmaceuticals, Inc. (ENZN) to Explore Sale of Company After Icahn Wants Talk
12/17/2012 7:35:17 AM
More...
|
Enzon Pharmaceuticals (Piscataway, New Jersey) (ENZN) Announces Special Dividend
11/30/2012 10:38:00 AM
More...
|
Enzon Pharmaceuticals, Inc. (ENZN) Reports Third Quarter 2012 Results
10/31/2012 11:08:20 AM
More...
|
Enzon Pharmaceuticals, Inc. (ENZN) to Present at 2012 World Congress and Expo on Biowaivers and Biosimilars
9/11/2012 9:20:31 AM
More...
|
Enzon Pharmaceuticals (Piscataway, New Jersey) (ENZN) Reports Second Quarter 2012 Results
8/1/2012 8:45:11 AM
More...
|
Enzon Pharmaceuticals, Inc. (ENZN) Presents Pre-Clinical Data on Controlled Release of PEGylated Interferon-Beta-1b and PEGylated anti-TNF-a Antibody Fragment at the Controlled Release Society Annual Meeting
7/16/2012 8:56:49 AM
More...
|
|